Mr Joshua Michael Severns, LCSW, ACADC in Plummer, ID - Social Worker

Mr Joshua Michael Severns, LCSW, ACADC is a Social Worker - Clinical based in Plummer, Idaho. Mr Joshua Michael Severns is licensed to practice in Idaho (license number LCSW-39053) and his current practice location is 427 N 12th Street, Plummer, Idaho. He can be reached at his office (for appointments etc.) via phone at (208) 686-1449.

NPI number for Mr Joshua Michael Severns is 1013447671 and his current mailing address is Po Box 388, Plummer, Idaho. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013447671.

Contact Information

	Mr Joshua Michael Severns, LCSW, ACADC
	427 N 12th Street, Plummer, ID 83851
	(208) 686-1449
	Not Available

Healthcare Provider's Profile

Full Name	Mr Joshua Michael Severns
Gender	Male
Speciality	Social Worker - Clinical
Location	427 N 12th Street, Plummer, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013447671
Provider Enumeration Date: 06/15/2017
Last Update Date: 11/18/2021

Medical Identifiers

Medical identifiers for Mr Joshua Michael Severns such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013447671	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	ACADC-13016 (Idaho)	Secondary
101YA0400X	Counselor - Addiction (substance Use Disorder)	LMSW-36753 (Idaho)	Secondary
101YA0400X	Counselor - Addiction (substance Use Disorder)	LCSW-39053 (Idaho)	Secondary
171M00000X	Case Manager/care Coordinator	LCSW-39053 (Idaho)	Secondary
1041C0700X	Social Worker - Clinical	LCSW-39053 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Joshua Michael Severns is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Joshua Michael Severns, LCSW, ACADC Po Box 388, Plummer, ID 83851-0388 Ph: (208) 686-1449	Mr Joshua Michael Severns, LCSW, ACADC 427 N 12th Street, Plummer, ID 83851 Ph: (208) 686-1449

News Archive

Roundup: Calif. wrestles with prison health costs; Texas legislator challenges GOP thinking; Mass. Gov. seeks remedy for municipal workers' health expenses

Amid California's budget crisis, the receiver put in charge of the prison health system by a federal judge has spent $82 million on blueprints for medical facilities that have been largely scrapped, more than $50,000 a month on an architectural consultant and millions hiring medical professionals — more per inmate than in many other states.

Mesoblast receives FDA clearance for heart attack stem cell trial

Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.

Study results of nucleoside polymerase and protease inhibitor combination therapy for HCV promising

All approved therapy regimens to treat patients with hepatitis C are based on interferon, which must be injected. In this clinical trial to be presented at the annual meeting of the American Association for the Study of Liver Diseases, researchers treated patients - both treatment naive and experienced patients - with a twice daily oral combination therapy of a nucleoside polymerase and protease inhibitor.

Ability for grammar hardwired into humans

Researchers have long wondered why certain fundamental characteristics of grammar are present in all languages, and now a team of scientists at the University of Rochester has found evidence that these properties are built into the way our brains work.

Transparent develops new medium for Cell-able array kit to maintain metabolite activity

Transparent Inc. announced that it has developed a more advanced medium for Cell-able, a human hepatocyte array kit that has the potential to reduce drug development costs and time-to-market for pharmaceutical companies. Transparent first introduced Cell-able in the United States a year ago.

Mr Joshua Michael Severns, LCSW, ACADC - Counselor in Plummer, ID